Candel Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced new results ...
Many U.S. utilities have completed, or are nearing completion of, their Advanced Metering Infrastructure (AMI) and Meter Data Management System (MDMS) rollouts. With these implementations completing, ...
AI agents are entering enterprise environments at machine speed, but the data-centric security controls needed to govern their access and behavior are still catching up, creating a new rift in ...
Artificial intelligence detection and response platform startup Manifold announced today that it has raised $8 million in funding to fuel development of its platform. The platform is designed to ...
For decades, we have adapted to software. We learned shell commands, memorized HTTP method names and wired together SDKs. Each interface assumed we would speak its language. In the 1980s, we typed ...
The primary analysis of EMBARK reported improved metastasis-free survival for enzalutamide plus leuprolide (enzalutamide combination) vs leuprolide plus placebo (leuprolide alone) in patients with ...
Utilities today are being asked to do more with less. From electrical grids and water systems to transportation networks, the pressure to deliver reliable, secure service continues to rise. Threats ...
When we launched UniOne, we didn’t set out to build yet another email platform. We were solving a very specific customer wish: They needed a fast, reliable way to send large volumes of emails through ...
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) on Tuesday received the final meeting minutes from its End of Phase 2 (EOP2) Meeting with the U.S. Food and Drug Administration (FDA) held in July. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results